Health
Medical
Biotechnology
bluebird bio
$120.029876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$120.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$3.03 (2.59%) Today
$0.00 (0.00%) As of 4:58 PM EDT after-hours
Why Robinhood?
You can buy or sell bluebird bio and other stocks, options, ETFs, and crypto commission-free!
About BLUE
bluebird bio, Inc. Common Stock, also called bluebird bio, is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Read More Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.
CEO
Employees
764
Headquarters
Cambridge, Massachusetts
Founded
1992
Market Cap
6.63B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
527.03K
High Today
$120.34
Low Today
$117.96
Open Price
$118.09
Volume
284.21K
52 Week High
$176.55
52 Week Low
$87.49
Collections
Health
Medical
Biotechnology
Cancer Prevention
Gene Therapies
Technology
Therapy
2013 IPO
Price Paid on Robinhood
19% Lower
Right Now
52 Week Low
$87.49
Average Price Paid
$147.65
52 Week High
$199.70
Analyst Ratings
68%
of 22 ratings
Buy
68%
Hold
32%
Sell
0%
BLUE Earnings
-$3.55
-$2.93
-$2.31
-$1.69
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Oct 31, After Hours